Clinical Trial: A Phase I clinical study of the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple doses of HSK55879 in participants with overweight or obesity (China)

Posted On: 2026-11-04

China, Nov. 4 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Phase I clinical study of the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple doses of HSK55879 in participants with overweight or obesity'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135882

Registration Time: 2026/11/03

Type: Interventional study

Primary Sponsor: The Second Hospital of Anhui Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=330539

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: A Phase I clinical study of the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple doses of HSK55879 in participants with overweight or obesity (China)